SLQTMEDIUM SIGNALMANAGEMENT10-K

SLQT is executing a strategic pivot from auto/home insurance distribution toward healthcare services, while significantly reducing debt levels and growing revenue.

The company's explicit de-emphasis of its Auto Home distribution business in favor of healthcare services like SelectRx and chronic care management represents a fundamental business model shift that could alter its risk profile and growth trajectory. This strategic repositioning, combined with substantial debt reduction, suggests management is actively reshaping the company's capital structure and market focus.

Comparing 2025-08-21 vs 2024-09-13View on EDGAR →
FINANCIAL ANALYSIS

The financial picture shows a company in transition with solid operational momentum and improving capital structure. Revenue grew meaningfully by 15.5% to $1.5B while total debt declined substantially from $683M to $385M, indicating either debt paydown or restructuring activities. The 16.6% increase in SG&A expenses likely reflects investments in the healthcare services expansion, while the modest decline in cash and capital expenditures suggests disciplined capital allocation during this strategic shift.

FINANCIAL STATEMENT CHANGES
Inventory
Balance Sheet
+57.3%
$5.6M→$8.8M

Inventory surged 57.3% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.

Total Debt
Balance Sheet
-43.6%
$683.3M→$385.1M

Debt reduced 43.6% — deleveraging strengthens balance sheet and reduces financial risk.

Capital Expenditure
Cash Flow
-35.2%
$3.4M→$2.2M

Capex reduced 35.2% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Cash & Equivalents
Balance Sheet
-24.1%
$42.7M→$32.4M

Cash decreased 24.1% — monitor burn rate and upcoming capital needs.

Total Liabilities
Balance Sheet
-23.2%
$877.1M→$673.8M

Liabilities reduced 23.2% — deleveraging improves balance sheet strength and financial flexibility.

Current Liabilities
Balance Sheet
+22%
$174.6M→$212.9M

Current liabilities rose 22% — increased short-term obligations, watch current ratio.

SG&A Expense
P&L
+16.6%
$141.0M→$164.4M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Revenue
P&L
+15.5%
$1.3B→$1.5B

Revenue growing 15.5% — solid top-line momentum, watch margins for quality of growth.

Stockholders Equity
Balance Sheet
+10.8%
$316.8M→$351.1M

Equity base grew 10.8% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2025-08-21
PRIOR — 2024-09-13
ADDED
The aggregate market value of the outstanding common stock held by non-affiliates of the Registrant as of December 31, 2024, the last business day of our most recently completed second fiscal quarter, based on the closing price of $3.72 reported by the New York Stock Exchange on that date, was $ 506,928,494 .
Solely for the purposes of this calculation, the Registrant has excluded shares held by the Registrant's directors and executive officers as of December 31, 2024.
The registrant had outstanding 172,816,730 shares of common stock as of July 31, 2025.
In recent years, we have increasingly focused on expanding our healthcare services platform as a natural extension of our core Senior distribution insurance business.
This strategic shift reflects our prioritization of higher-growth opportunities in areas such as pharmacy services and chronic care management through offerings like SelectRx and SelectPatient Management ( SPM ).
+7 more — sign up free →
REMOVED
The aggregate market value of the outstanding common stock held by non-affiliates of the Registrant as of December 29, 2023, the last business day of our most recently completed second fiscal quarter, based on the closing price of $1.37 reported by the New York Stock Exchange on that date, was $ 184,808,919 .
Solely for the purposes of this calculation, the Registrant has excluded shares held by the Registrant's directors and executive officers as of December 29, 2023.
The registrant had outstanding 171,443,421 shares of common stock as of August 31, 2024.
Our proprietary technology allows us to take a broad funnel approach to marketing by analyzing and identifying high-quality consumer leads sourced from a wide variety of online and offline marketing channels including digital marketing, radio, television, and third-party marketing partners.
We monitor our acquisition costs to dynamically allocate our marketing spend to the most attractive channels, benefiting from nearly 40 years of data accumulated through our proprietary, purpose-built technologies.
+7 more — sign up free →
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →